•
Jun 30, 2019

ALX Oncology Q2 2019 Earnings Report

Total Revenue
$1.3M
EPS
-$0.191
R&D Expenses
$3.6M
G&A Expenses
$700K
Gross Profit
$118K

ALX Oncology

ALX Oncology

ALX Oncology Revenue by Segment